BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7997454)

  • 1. Comparison of villous trophoblast proliferation rate in hydatidiform mole and non-molar abortion by assessment of proliferating cell nuclear antigen expression.
    Jeffers MD; Grehan D; Gillan JE
    Placenta; 1994 Jul; 15(5):551-6. PubMed ID: 7997454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
    Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proliferation cell nuclear antigen immunoreactivity for distinguishing hydropic abortions from partial hydatidiform moles.
    Suresh UR; Hale RJ; Fox H; Buckley CH
    J Clin Pathol; 1993 Jan; 46(1):48-50. PubMed ID: 8094402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases.
    Uzunlar AK; Yilmaz F; Bayhan G; Akkuş Z
    Eur J Gynaecol Oncol; 2002; 23(1):79-83. PubMed ID: 11876401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histological differential diagnosis of hydatidiform moles and hydropic abortions].
    Zavadil M; Feyereisl J; Hejda V; Krofta L; Safár P
    Cesk Patol; 2009 Jan; 45(1):3-8. PubMed ID: 19402314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathological features of hydatidiform moles and placenta changes of nonmolar miscarriage in early stage of pregnancy].
    Dong Y; Zhang S; Wang ML; Guo H; Zhang Y; Wang Y; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):194-8. PubMed ID: 21503111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vasculogenesis--a possible histological identification criterion for the molar pregnancy.
    Novac L; Niculescu M; Manolea MM; Iliescu D; Georgescu CV; Comănescu A; Cernea N; Enache A
    Rom J Morphol Embryol; 2011; 52(1):61-7. PubMed ID: 21424033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic testing from paraffin-embedded tissue distinguishes nonmolar hydropic abortion from hydatidiform mole.
    Bell KA; Van Deerlin V; Addya K; Clevenger CV; Van Deerlin PG; Leonard DG
    Mol Diagn; 1999 Mar; 4(1):11-9. PubMed ID: 10229770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole.
    Cheville JC; Robinson R; Benda JA
    Pediatr Pathol Lab Med; 1996; 16(1):41-50. PubMed ID: 8963630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New diagnostic approach to different hydatidiform mole types, hydropic abortions and relevant clinical management].
    Zavadil M; Feyereisl J; Krofta L; Safár P; Kucerová I
    Ceska Gynekol; 2009 Jun; 74(3):177-82. PubMed ID: 19642515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative activity in placentas with hydropic change and hydatidiform mole as detected by Ki-67 and proliferating cell nuclear antigen immunostaining.
    Ostrzega N; Phillipson J; Liu P
    Am J Clin Pathol; 1998 Dec; 110(6):776-81. PubMed ID: 9844590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen.
    Cheung AN; Ngan HY; Collins RJ; Wong YL
    J Clin Pathol; 1994 Jul; 47(7):601-4. PubMed ID: 8089214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole.
    Jeffers MD; Richmond JA; Smith R
    Int J Gynecol Pathol; 1996 Jan; 15(1):34-8. PubMed ID: 8852444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do AgNOR counts reflect cellular ploidy or cellular proliferation? A study of trophoblastic tissue.
    Suresh UR; Chawner L; Buckley CH; Fox H
    J Pathol; 1990 Mar; 160(3):213-5. PubMed ID: 2335802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study.
    Schammel DP; Bocklage T
    Int J Gynecol Pathol; 1996 Apr; 15(2):158-66. PubMed ID: 8786206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas.
    Fukunaga M
    Arch Pathol Lab Med; 2004 Aug; 128(8):897-900. PubMed ID: 15270611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molar gestations and hydropic abortions differentiated by p57 immunostaining.
    Romaguera RL; Rodriguez MM; Bruce JH; Zuluaga T; Viciana A; Penalver MA; Mehrdad N
    Fetal Pediatr Pathol; 2004; 23(2-3):181-90. PubMed ID: 15768863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of p63 in hydropic and molar gestations.
    Masood S; Kehar SI; Shawana S; Aamir I
    J Coll Physicians Surg Pak; 2015 Mar; 25(3):198-201. PubMed ID: 25772961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.